The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The imaging substudy of the randomized ARTE trial: MRI and 18FET PET associations with overall survival benefit from bevacizumab in elderly patients with newly diagnosed IDH wildtype glioblastoma.
 
Hans-Georg Wirsching
No Relationships to Disclose
 
Ulrich Roelcke
No Relationships to Disclose
 
Jonathan Weller
No Relationships to Disclose
 
Thomas Hundsberger
No Relationships to Disclose
 
Andreas Felix Hottinger
No Relationships to Disclose
 
Roger Anton Fredy Von Moos
Honoraria - AstraZeneca (Inst); Bayer/Onyx; Roche
Consulting or Advisory Role - Amgen (Inst); Bayer/Onyx (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst); Roche/Genentech (Inst); Tesaro
Research Funding - Bayer/Onyx (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - Pfizer
Other Relationship - Pfizer
 
Francesca Caparrotti
No Relationships to Disclose
 
Katrin Lisa Conen
No Relationships to Disclose
 
Luca Remonda
No Relationships to Disclose
 
Patrick Roth
Honoraria - Merck; Novocure; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Debiopharm Group; MSD; MSD (Inst); Virometix
Research Funding - MSD (Inst)
 
Adrian Ochsenbein
No Relationships to Disclose
 
Ghazaleh Tabatabai
Honoraria - Abbvie; Bayer; Medac; Novocure (Inst)
Consulting or Advisory Role - Abbvie; Abbvie; Bayer
Travel, Accommodations, Expenses - Novocure (Inst)
 
Michael Weller
Honoraria - Abbvie; Merck Serono; MSD
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Karyopharm Therapeutics; Merck Serono; Orbus Therapeutics; Tocagen
Research Funding - Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novocure (Inst); OGD2 Pharma (Inst); Piqur (Inst); Roche (Inst); Tragara (Inst)